Home » Health Care

Drug Discovery and Development

BioBytes - Biotechnology and food flavoring

Dr. Targan explains how the biotech industry is using the biology of taste to create healthier sweeteners, block bitter tastes, and help make unpleasant-tasting medicines more palatable.

Biologics bill will help make breakthrough drugs more widely available
BioBytes 108 - What are Stem Cells?

What's a stem cell? Where does it come from? Learn more about how biotechnology is utilizing stem cells to create tomorrow's cures for today's diseases.

BioBytes 104 - What is personalized medicine?

Personalized medicine will change the way patients are treated in the future - for the better. Learn more about personalized medicine - how it works, and why it could save consumers a lot of money.

BioBytes 101 - What is biotechnology?

This video provides a basic overview of biotechnology and its many applications in our daily lives.

BioBytes 103 - What are biotech drugs?

Are biotech drugs really that different from traditional pharmaceuticals.  You bet they are.  Learn why here.

The Ubiquitin Proteasome System: Deja Vu, or Something New?
Developing Drugs for Rare Diseases
The Right Fit for Companion Technologies
Developing drugs and companion diagnostics
The Importance of President Obama's Executive Order on Embryonic Stem Cells

In this interview, BIO President and CEO Jim Greenwood explains the promise of stem cell research and why it is an important first step in bringing new therapies to patients.

Guide to Biotechnology 2008

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

2007-2008 BIO Milestones

Today, the biotechnology industry is enjoying more success and influence than ever before. Our industry’s innovations continue to improve the lives of people worldwide, and the advancement of these innovations is supported by the work of BIO.

Alzheimer's: Searching for a Cure

Learn about one of the paths scientists are taking in the search for a cure for Alzheimer's.

Growing The Nation's Biotech Sector

States and regions throughout the United States are investing to create a business climate that supports the specific needs of the biosciences sector.

Letters, Testimony & Comments

Recombinant DNA: BIO Comments on WHO Guidelines on the Quality, Safety, and Efficacy of Biological Medicinal Products Prepared by Recombinant DNA Technology
April 19 2013
  The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the “WHO Guidelines on the Quality...
Immunogenicity: BIO Comments on Draft Guidance on Immunogenicity Assessment for Therapeutic Protein Products
April 12 2013
Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the opportunity to...
eSource: BIO Comments on FDA Draft Guidance on Electronic Source Data in Clinical Investigations
March 26 2013
  Re: Docket No. FDA–2010-D-0643:  Draft Guidance for Industry on Electronic Source Data in Clinical Investigations;...
Enrichment Strategies: BIO Submits Comments on FDA Draft Guidance on Enrichment Strategies for Clinical Trials
March 18 2013
  Dear Sir/Madam:   The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA) for the...
eCTD: BIO Submits Comments on Providing Regulatory Submissions in Electronic Format
March 4 2013
  The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to...
More Letters, Testimony & Comments →

Press Releases

IFPMA, BIO and WADA Advance Anti-Doping Collaboration with the Launch of 2 Fields 1 Goal Campaign
July 23 2012
Groups Issue Booklet to Help Biotechnology and Pharmaceutical Companies Identify Pipeline Medicines with Doping...
BIO Supports Permanent Reauthorization of Programs to Encourage Development of Lifesaving Medications for Children
March 28 2012
Washington, D.C. (March 28, 2012) – BIO President and CEO Jim Greenwood issued the following statement in...
BIO Statement on New Bill to Extend Therapeutic Discovery Project Tax Credit
May 25 2011
WASHINGTON, D.C. (Wednesday, May 25, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
Representative Upton Honored as BIO Legislator of the Year
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
Senator Casey Honored as BIO Legislator of the Year
May 4 2011
Pennsylvania Bio President Christopher Molineaux and BIO President and CEO Jim Greenwood present Senator...
More Press Releases →